Replimune Group, Inc. (REPL) vs Vor Biopharma Inc. (VOR)
Replimune Group, Inc. and Vor Biopharma Inc. are both Biotechnology companies. Replimune Group, Inc. is the larger, with a market value of $1.2B against $1.1B — 1.1× the size. Across the 10 metrics below, Vor Biopharma Inc. leads on 7 and Replimune Group, Inc. on 3.
Valuation
Profitability
| Metric | REPL | VOR | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | — | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (134.29%) | (69.27%) | (57.72%) |
| Return on assets | (82.28%) | 0.00% | (49.22%) |
| Return on invested capital | (1,154.69%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack